申请人:MITSUBISHI KASEI CORPORATION
公开号:EP0150469A1
公开(公告)日:1985-08-07
This invention relates novel thieno[2,3-d]pyrimidine derivatives represented by the following general formula (I):
or salts thereof; wherein R1 and R2 independently represent hydrogen, halogen or alkyl group having 1 to 6 carbon atoms; or R1 and R2 may concatenate to form a cycloalkylene group having 5 or 6 ring carbon atoms; R3 and R4 independently represent hydrogen or alkyl group having 1 to 6 carbon atoms; R5 represents a member selected from
(1) hydrogen or alkyl having 1 to 6 carbon atoms,
is an integer of from 1 to 3 and X represents halogen, or
(3)
in which R6 represents alkyl group having 1 to 6 carbon atoms;
Ar represents substituted or unsubstituted phenyl, or 2- or 3-thienyl group; and n is 2 or 3. The derivatives of the invention can be used in the treatment of the various depression disease or the higher dysfunction of the brain.
本发明涉及以下一般式(I)所表示的新型噻唑[2,3-d]嘧啶衍生物或其盐;其中,R1和R2独立地表示氢、卤素或具有1至6个碳原子的烷基;或者R1和R2可以连接形成具有5或6个环碳原子的环烷基;R3和R4独立地表示氢或具有1至6个碳原子的烷基;R5表示从(1)氢或具有1至6个碳原子的烷基,n为1至3的整数,X表示卤素,或者(3)式中,R6表示具有1至6个碳原子的烷基;Ar表示取代或未取代的苯基,或2-或3-噻吩基;n为2或3。本发明的衍生物可用于治疗各种抑郁症或大脑高级功能障碍。